Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Current Alzheimer Research
|
October 3, 2007
East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A
W M Li, K K W Kan, P R Carlier, et al.
Bioorganic & Medicinal Chemistry
|
January 13, 2000
Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities
Y F Han, C P Li, E Chow, et al.
Journal of Medicinal Chemistry
|
October 9, 1999
Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions
P R Carlier, E S Chow, Y Han, et al.
Journal of Medicinal Chemistry
|
February 12, 2000
Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads
E Perola, K Xu, T M Kollmeyer, et al.
Journal of Neurophysiology
|
June 30, 2001
Effects of bis(7)-tacrine on spontaneous synaptic activity and on the nicotinic ACh receptor of Torpedo electric organ
E Ros, J Aleu, I Gomez de Aranda, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|
August 19, 1999
Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor
H Wang, P R Carlier, W L Ho, et al.
Journal of Medicinal Chemistry
|
May 1, 1992
Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency
C Chen, A P Kozikowski, P L Wood, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1999
Atomic levers control pyranose ring conformations
P E Marszalek, Y P Pang, H Li, et al.
Current Medicinal Chemistry
|
May 29, 2001
A new form of antiviral combination therapy predicted to prevent resistance from arising, and a model system to test it
W F Mangel, W J McGrath, M T Brown, et al.
FEBS Letters
|
October 5, 2001
Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases
Y P Pang, K Xu, T M Kollmeyer, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Current Alzheimer Research
|
October 3, 2007
East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A
W M Li, K K W Kan, P R Carlier, et al.
Bioorganic & Medicinal Chemistry
|
January 13, 2000
Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities
Y F Han, C P Li, E Chow, et al.
Journal of Medicinal Chemistry
|
October 9, 1999
Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions
P R Carlier, E S Chow, Y Han, et al.
Journal of Medicinal Chemistry
|
February 12, 2000
Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads
E Perola, K Xu, T M Kollmeyer, et al.
Journal of Neurophysiology
|
June 30, 2001
Effects of bis(7)-tacrine on spontaneous synaptic activity and on the nicotinic ACh receptor of Torpedo electric organ
E Ros, J Aleu, I Gomez de Aranda, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|
August 19, 1999
Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor
H Wang, P R Carlier, W L Ho, et al.
Journal of Medicinal Chemistry
|
May 1, 1992
Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency
C Chen, A P Kozikowski, P L Wood, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1999
Atomic levers control pyranose ring conformations
P E Marszalek, Y P Pang, H Li, et al.
Current Medicinal Chemistry
|
May 29, 2001
A new form of antiviral combination therapy predicted to prevent resistance from arising, and a model system to test it
W F Mangel, W J McGrath, M T Brown, et al.
FEBS Letters
|
October 5, 2001
Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases
Y P Pang, K Xu, T M Kollmeyer, et al.
Page
of 5